What We Provide

Public Companies

We work with private companies seeking liquidity through a public listing strategy or listed companies seeking additional private investment. We are sector agnostic and engage with small to mid-cap companies ranging in valuation from $50M up to $10BLN. Exchange venues of focus include the United States, Canada, Europe, Asia and Australia.

“I have worked with the Accurent team for close to 2 years, advising my biotech Company, Green Sky Labs. The team successfully placed $170M in equity financing from a US-based hedge fund and has been instrumental in navigating institutional investor relationships and strategic partnership discussions in the US and Europe. I look forward to continued engagement with the Accurent team as GSL, and its subsidiary My Next Health, position for IPO in 2022.”

— Rehan Huda, CEO, Green Sky Labs

Explore Your Strategic Options